|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 63/00 | |
| C12N 5/00 | |||
| C12N 15/00 | |||
| C12N 15/87 | |||
| C12P 21/04 | |||
| C07H 21/04 |
| (11) | Number of the document | 3057432 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14853797.0 |
| Date of filing the European patent application | 2014-10-16 | |
| (97) | Date of publication of the European application | 2016-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/060918 |
| Date | 2014-10-16 |
| (87) | Number | WO 2015/057976 |
| Date | 2015-04-23 |
| (30) | Number | Date | Country code |
| 201361892340 P | 2013-10-17 | US |
| (72) |
GENOVESE, Pietro, IT
GREGORY, Philip D., US
HOLMES, Michael C., US
LOMBARDO, Angelo Leone, IT
NALDINI, Luigi, IT
|
| (73) |
Ospedale San Raffaele S.r.l.,
Via Olgettina 60, 20132 Milano,
IT
Fondazione Telethon, Via Varese 16B, 00185 Roma, IT Sangamo Therapeutics, Inc., 501 Canal Blvd. Suite A100, Richmond, CA 94804, US |
| (54) | DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING IN HEMATOPOIETIC STEM CELLS |
| DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING IN HEMATOPOIETIC STEM CELLS |